Why Choose Private Prescription for Weight Management Medications?
1mg Wegovy Compared to Mounjaro: Private vs NHS Route
When comparing 1mg of Wegovy to Mounjaro through private prescription in the UK, the advantages over NHS routes become immediately apparent. The NHS pathway typically requires GP referral to specialist weight management services, often involving 6+ month waiting lists and strict BMI criteria. Private prescription eliminates these barriers entirely, offering the same genuine Novo Nordisk Wegovy and Eli Lilly Mounjaro through a streamlined 3-minute clinical assessment. This approach allows patients to access either 1mg Wegovy or equivalent Mounjaro doses without the frustration of prolonged waiting periods.
The private prescription model ensures continuity of treatment, particularly crucial during dose escalation phases where 1mg represents weeks 9-12 of the Wegovy protocol. Unlike NHS supply interruptions, private prescription ensures medication availability, allowing patients to maintain their treatment momentum. Both medications require identical prescription-only medicine protocols, but private access removes the administrative complexity of NHS specialist referrals.
1mg Wegovy vs Mounjaro Pricing: Transparent Private Prescription Costs
Our 1mg Wegovy costs £99.99 per pen, with new customers receiving code FIRST40 and returning patients using DOSE25 applied at checkout to reach these final prices. The Advance Duo bundle (1mg + 1.7mg) provides continuity at £269.99, bridging the crucial transition from mid-escalation to higher maintenance doses. Mounjaro pricing follows a different structure due to its unique dual-agonist mechanism, but both options remain accessible through our private prescription service.
When comparing 1mg of Wegovy to Mounjaro, cost considerations extend beyond individual pen prices to include storage advantages and dosing flexibility. Wegovy's 6-week room temperature stability compared to Mounjaro's 21-day window can reduce medication waste, particularly valuable at the £99.99 price point for 1mg doses. Our transparent pricing eliminates hidden NHS prescription charges while providing assured medication access.
Clinical Evidence: 1mg Wegovy Compared to Mounjaro Mechanisms
The fundamental difference when comparing 1mg of Wegovy to Mounjaro lies in their receptor mechanisms. Wegovy (semaglutide) functions as a selective GLP-1 receptor agonist, while Mounjaro (tirzepatide) operates as a dual GIP and GLP-1 receptor agonist. Clinical trials including the landmark STEP studies (Wilding et al., NEJM, 2021) demonstrated that patients taking Wegovy alongside diet and exercise may achieve significant weight management outcomes during the 1mg escalation phase.
Both medications work through appetite regulation centres in the brain, but their distinct mechanisms may suit different patient profiles. The 1mg Wegovy dose typically represents a crucial midpoint where appetite suppression becomes well-established, occurring around weeks 9-12 of treatment. Comparative effectiveness cannot be directly assessed due to different trial designs and patient populations between STEP and SURMOUNT studies.
How 1mg Wegovy Works: GLP-1 Mechanism at Mid-Escalation
At the 1mg dose level, Wegovy's semaglutide mechanism reaches therapeutic levels that significantly impact appetite regulation. The medication mimics the natural GLP-1 hormone, binding to receptors in the brain's appetite control centres and digestive system. This dual action promotes earlier satiety after smaller meals while reducing food cravings throughout the day. The 1mg dose represents a critical escalation point where many patients begin experiencing substantial appetite suppression effects. Unlike Mounjaro's dual-agonist approach, Wegovy's singular GLP-1 focus provides targeted, predictable appetite regulation that builds systematically through the dose escalation protocol.
Ordering 1mg Wegovy vs Mounjaro: Streamlined Private Prescription Process
Our private prescription process for both 1mg Wegovy and Mounjaro begins with a comprehensive 3-minute online clinical assessment, eliminating the need for GP referrals or specialist appointments. Following assessment submission, our qualified prescribers review applications within 3 working days (24-hour express option available), evaluating suitability for either medication based on individual circumstances. Upon approval, medications are dispatched via next-day cold-chain delivery, maintaining the temperature-controlled storage essential for both semaglutide and tirzepatide stability. This streamlined approach ensures patients can begin their chosen treatment without NHS waiting list delays. The entire process from assessment to delivery typically completes within one week, compared to months through traditional NHS pathways.
Storage and Practical Considerations: 1mg Wegovy Compared to Mounjaro
When comparing 1mg of Wegovy to Mounjaro for practical use, storage requirements present a significant differentiator. Both medications require refrigeration at 2-8°C before first use, but Wegovy maintains stability for 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day window. This extended stability makes Wegovy particularly suitable for travel or irregular schedules common during the demanding mid-escalation phase. The FlexTouch pen system used for 1mg Wegovy delivers precise dosing through a user-friendly interface, while both medications require once-weekly administration on the same day each week. Proper storage becomes crucial at the £99.99 price point, where medication waste due to temperature exposure represents significant financial impact.
1mg Wegovy vs Mounjaro: Dose Escalation Timing Comparison
The 1mg Wegovy dose occurs during weeks 9-12 of the standard escalation protocol, representing a midpoint where patients typically experience established appetite suppression alongside measurable weight management progress. This timing differs from Mounjaro's escalation schedule, which follows alternative dosing increments suited to its dual-agonist mechanism. At 1mg, Wegovy patients often report significant changes in food preferences and portion sizes, indicating the medication's appetite-regulating effects are reaching therapeutic levels.
Transitioning from 1mg to the subsequent 1.7mg dose requires careful monitoring, as this represents one of the larger dose increases in the Wegovy protocol. Unlike Mounjaro's dose escalation pattern, Wegovy's systematic approach ensures patients adapt gradually to increasing semaglutide levels. The Advance Duo bundle at £269.99 provides seamless transition from 1mg to 1.7mg, eliminating potential treatment gaps during this crucial escalation phase.
Private Prescription Advantages: Same-Day Prescriber Consultations
EverydayMeds' private prescription model enables same-day prescriber consultations for patients comparing 1mg of Wegovy to Mounjaro, offering personalised guidance unavailable through standard NHS channels. Our qualified prescribers assess individual factors including medical history, concurrent medications, and lifestyle considerations to recommend the most appropriate treatment option. This personalised approach proves invaluable when determining whether semaglutide's singular GLP-1 mechanism or tirzepatide's dual-agonist action better suits individual circumstances. The consultation process includes detailed explanation of both medications' mechanisms, expected timelines, and practical considerations specific to private prescription access. Our GPhC registered pharmacy (#9012878) ensures all prescriptions meet identical standards to NHS supply while eliminating access barriers.
Ready to start your weight management journey? Our 1mg Wegovy is available for £99.99 with discount codes applied at checkout, alongside expert prescriber support to determine whether Wegovy or Mounjaro aligns with your goals. Complete our 3-minute assessment today to access genuine, temperature-controlled medications without NHS waiting lists. New customers use code FIRST40, while returning patients apply DOSE25 for these competitive prices. Visit our 1mg Wegovy product page to begin your private prescription journey with confidence. Both options represent prescription-only medicines requiring clinical assessment, but our streamlined process ensures you can start treatment within days rather than months.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
